Novel aspects of pharmacological therapies for acute renal failure

Drugs

Volumn 70, Issue 9, 2010, Pages 1099-1114

  Kunzendorf, Ulrich ^a   Haase, Michael ^b   Rölver, Lars ^a   Haase Fielitz, Anja ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biomarkers; Clonidine, therapeutic use; Diltiazem, therapeutic use; Dopamine, therapeutic use; Erythropoietins, therapeutic use; Fenoldopam, therapeutic use; Furosemide, therapeutic use; HMG CoA reductase inhibitors, therapeutic use

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; ATRIAL NATRIURETIC FACTOR; BICARBONATE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN INHIBITOR; CREATININE; DEXAMETHASONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ERYTHROPOIETIN; FATTY ACID BINDING PROTEIN; FENOLDOPAM; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITROPRUSSIDE SODIUM; NONIONIC CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; THEOPHYLLINE; UNINDEXED DRUG; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; APOPTOSIS; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DEHYDRATION; DISEASE SEVERITY; DRUG MEGADOSE; ENDOTHELIUM CELL; EXPOSURE; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INFLAMMATION; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; LOW DRUG DOSE; MORBIDITY; MORTALITY; NEPHROTOXICITY; NONHUMAN; OLIGURIA; PROGNOSIS; RENAL REPLACEMENT THERAPY; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; TREATMENT INDICATION;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77953171750     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11535890-000000000-00000     Document Type: Review

References (151)

1. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008 Apr; 36 (4): 1129-1137
2. Zappitelli M, Bernier PL, Saczkowski RS, et al. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 2009 Oct; 76 (8): 885-892
3. Marketos SG, Eftychiadis AG, Diamandopoulos A. Acute renal failure according to ancient Greek and Byzantine medical writers. J R Soc Med 1993 May; 86 (5): 290-293
4. Schrier RW, Wang W, Poole B, et al. Acute renal failure: definitions, diagnosis, pathogenesis and therapy. J Clin Invest 2004 Jul; 114 (1): 5-14
5. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005 Jan 29-Feb 4; 365 (9457): 417-430
6. Venkataraman R. Can we prevent acute kidney injury? Crit Care Med 2008 Apr; 36 (4 Suppl.): S166-71
7. Hoste E, Kellum J, Bellomo R, et al. What is acute kidney injury? In: Ronco C, Bellomo R, Kellum J, editors. Critical care nephrology. Philadelphia (PA): Saunders, 2009: 67-71
8. Bellomo R, Ronco C, Kellum JA, et al., on behalf of the Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12
9. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney In-jury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
10. Vincent JL, Moreno R, Takala J, et al., on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996 Jul; 22 (7): 707-710
11. Uchino S, Kellum JA, Bellomo R, et al., on behalf of the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294 (7): 813-818
12. Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006 Jul; 34 (7): 1913-1917 (Pubitemid 43982467)
13. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983 Feb; 74 (2): 243-248
14. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005 Nov; 16 (11): 3365-3370
15. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002 Sep; 30 (9): 2051-2058
16. Cosentino F, Chaff C, Piedmonte M. Risk factors influ-encing survival in ICU acute renal failure. Nephrol Dial Transplant 1994; 9 Suppl. 4: 179-182
17. Devarajan P. The strong silent type: the distal tubule to the rescue. Crit Care Med 2009 Jun; 37 (6): 2129-2130
18. US Renal Data System. Incidence of reported ESRD: 2006 annual data report [online]. Available from URL: http://www.usrds.org/2006/ref/A-incidence-06.pdf [Accessed 2006 Dec 26]
19. Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM 1996 Jun; 89 (6): 415-421
20. Morgera S, Kraft AK, Siebert G, et al. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 2002 Aug; 40 (2): 275-279
21. Mehta RH, Grab JD, O'Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006 Nov 21; 114 (21): 2208-2216
22. Ympa YP, Sakr Y, Reinhart K, et al. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005 Aug; 118 (8): 827-832
23. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006 Jul; 2 (7): 364-377
24. Porter GA, Palmer BF, Henrich WL. Clinical relevance. In: De Broe ME, Porter GA, Bennett WM, et al. editors. Clinical nephrotoxins. Dordrecht: Kluwer Academic Publishers, 2003: 3-21
25. Nash K, Hafeez A, Hou S. Hospital-acquired renal in-sufficiency. Am J Kidney Dis 2002 May; 39 (5): 930-936
26. Feltes CM, Van Eyk J,Rabb H.Distant-organ changes after acute kidney injury. Nephron Physiol 2008; 109 (4): 80-84
27. Rabb H, WangZ, Nemoto T, et al. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 2003 Feb; 63 (2): 600-606
28. Liu M, Liang Y, Chigurupati S, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 2008 Jul; 19 (7): 1360-1370
29. Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2007 Mar; 2 (2): 356-365
30. Thakar CV, Liangos O, Yared JP, et al. ARF after open-heart surgery: influence of gender and race. Am J Kidney Dis 2003 Apr; 41 (4): 742-751
31. Chertow GM, Lazarus JM, Christiansen CL, et al. Pre-operative renal risk stratification. Circulation 1997 Feb 18; 95 (4): 878-884
32. Aronson S, Fontes ML, Miao Y, et al. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation 2007 Feb 13; 115 (6): 733-742
33. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006 Jan; 1 (1): 19-32
34. Brown JR, Cochran RP, Leavitt BJ, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation 2007 Sep 11; 116 (11 Suppl.): I139-43
35. Vaccarino V, Abramson JL, Veledar E, et al. Sex differ-ences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation 2002 Mar 12; 105 (10): 1176-1181
36. Tyson 3rd GH, Rodriguez E, Elci OC, et al. Cardiac pro-cedures in patients with a body mass index exceeding 45: outcomes and long-term results. Ann Thorac Surg 2007 Jul 84 (1) 3-9
37. Engelman DT, Adams DH, Byrne JG, et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 1999 Nov; 118 (5): 866-873
38. Mentzer Jr RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial. J Am Coll Cardiol 2007 Feb 13; 49 (6): 716-726
39. Bove T, Landoni G, Calabro MG, et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005 Jun 21; 111 (24): 3230-3235
40. Haase M, Haase-Fielitz A, Bellomo R, et al. Sodium bi-carbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009 Jan; 37 (1): 39-47
41. Haase M, Haase-Fielitz A, Bagshaw SM, et al. Phase II, randomized, controlled trial of high-dose N-acetyl-cysteine in high-risk cardiac surgery patients. Crit Care Med 2007 May; 35 (5): 1324-1331
42. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000 Dec 23-30; 356 (9248): 2139-2143
43. Conger JD. Interventions inclinical acute renal failure: what are the data? Am J Kidney Dis 1995 Oct; 26 (4): 565-576
44. Ronco C, Bellomo R. Prevention of acute renal failure in the critically ill. Nephron Clin Pract 2003 Jan; 93 (1): C13-20
45. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002 Feb 11; 162 (3): 329-336
46. Martin GS, Lewis CA. Fluid management in shock. Semin Respir Crit Care Med 2004 Dec; 25 (6): 683-693
47. Schetz M, Bove T, Morelli A, et al. Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs 2008 Feb; 31 (2): 179-189
48. Brienza N, Giglio MT, Marucci M, et al. Does periopera-tive hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009 Jun; 37 (6): 2079-2090
49. Heinrich MC, Haberle L, Muller V, et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009 Jan; 250 (1): 68-86
50. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial-the Iohexol Cooperative study. Kidney Int 1995 Jan; 47 (1): 254-261
51. Aspelin P, Aubry P, Fransson SG, et al., on behalf of the Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003 Feb 6; 348 (6): 491-499
52. Fergusson DA, Hebert PC, Mazer CD, et al., on behalf of the BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008 May 29; 358 (22): 2319-2331
53. Trivedi H, Daram S, Szabo A, et al. High-dose N-acetyl-cysteine for the prevention of contrast-induced nephropathy. Am J Med 2009 Sep; 122 (9): 874. e9-15
54. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angio-plasty. N Engl J Med 2006 Jun 29; 354 (26): 2773-2782
55. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008 Feb 19; 148 (4): 284-294
56. Navaneethan SD, Singh S, Appasamy S, et al. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 2009 Apr; 53 (4): 617-627
57. Meier P, Ko DT, Tamura A, et al. Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Med 2009 May 13; 7: 23
58. Kanbay M, Covic A, Coca SG, et al. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol 2009; 41 (3): 617-627
59. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 2000 Jan; 20 (1): 4-19
60. Briguori C, Airoldi F, D'Andrea D, et al. Renal In-sufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007 Mar 13; 115 (10): 1211-1217
61. Xinwei J, Xianghua F, Jing Z, et al. Comparison of use-fulness of simvastatin 20mg versus 80mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 2009 Aug 15; 104 (4): 519-524
62. Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; 30 (3): 253-260
63. Morikawa S, Sone T, Tsuboi H, et al. Renal protective effects and the prevention of contrast-induced nephro-pathy by atrial natriuretic peptide. J Am Coll Cardiol 2009 Mar 24; 53 (12): 1040-1046
64. Sezai A, Hata M, Niino T, et al. Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study. J Am Coll Cardiol 2009 Sep 15; 54 (12): 1058-1064
65. Morelli A, Ricci Z, Bellomo R, et al. Prophylactic fe-noldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 2005 Nov; 33 (11): 2451-2456
66. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007 Jan; 49 (1): 56-68
67. Kaya K, Oguz M, Akar AR, et al. The effect of sodium nitroprusside infusion on renal function during reperfu-sion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 2007 Feb; 31 (2): 290-297
68. Hoffmann H, Markewitz A, Kreuzer E, et al. Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 1998 Apr; 9 (4): 235-240
69. Boldt J, Brosch C, Piper SN, et al. Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 2001 May; 29 (5): 952-958 (Pubitemid 32424344)
70. Piper SN, Kumle B, Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth 2003 Mar; 50 (3): 285-292
71. Zanardo G, Michielon P, Rosi P, et al. Effects of a continuous diltiazem infusion on renal function during cardiac surgery. J Cardiothorac Vasc Anesth 1993 Dec; 7 (6): 711-716
72. Kulka PJ, Tryba M, Zenz M, et al. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 1996 Jun; 24 (6): 947-952
73. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009 Jun 17; 301 (23): 2445-2452
74. Amoureux MC, Hegyi E, Le D, et al. A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for ex-tracorporeal treatment of septic patients. J Endotoxin Res 2004; 10 (2): 85-95
75. Myles PS, Buckland MR, Schenk NJ, et al. Effect of "renal-dose'' dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993 Feb; 21 (1): 56-61
76. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000 Jan; 11 (1): 97-104
77. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldo-pam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003 Nov 5; 290 (17): 2284-2291
78. Kramer BK, Preuner J, Ebenburger A, et al. Lack of re-noprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 2002 May; 17 (5): 910-915
79. Morariu AM, Loef BG, Aarts LP, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting-a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005 Oct; 128 (4): 2677-2687
80. Loef BG, Henning RH, Epema AH, et al. Effect of dexa-methasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2004 Dec; 93 (6): 793-798
81. Wijeysundera DN, Beattie WS, Rao V, et al. N-acetyl-cysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anaesth 2007 Nov; 54 (11): 872-881
82. Ristikankare A, Kuitunen T, Kuitunen A, et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006 Nov; 97 (5): 611-616
83. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994 Nov 24; 331 (21): 1416-1420
84. Haase M, Haase-Fielitz A. Kidney failure following cardiovascular surgery. In: Jorres A, Ronco C, Kellum JA, editors. Management of acute kidney problems. Berlin: Springer, 2010: 413-428
85. Haase-Fielitz A, Haase M, Bellomo R, et al. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009 Jun; 20 (6): 1393-1403
86. Bellomo R, Wan L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med 2008 Apr; 36 (4 Suppl.): S179-86
87. Tolwani A, Paganini E, Joannidis M, et al. Treatment of patients with cardiac surgery associated-acute kidney injury. Int J Artif Organs 2008 Feb; 31 (2): 190-196
88. Davis RF, Lappas DG, Kirklin JK, et al. Acute oliguria after cardiopulmonary bypass: renal functional improvement with low-dose dopamine infusion. Crit Care Med 1982 Dec; 10 (12): 852-856
89. Lauschke A, Teichgraber UK, Frei U, et al. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006 May; 69 (9): 1669-1674
90. Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003 Aug; 17 (4): 491-494
91. Barr LF, Kolodner K. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med 2008 May; 36 (5): 1427-1435
92. Halpenny M, Lakshmi S, O'Donnell A, et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001 Oct; 56 (10): 953-960
93. Valsson F, Ricksten SE, Hedner T, et al. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996 Mar; 22 (3): 230-236
94. Sward K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004 Jun; 32 (6): 1310-1315
95. Abraham E, Laterre PF, Garg R, et al., on behalf of the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group. Drotre-cogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005 Sep 29; 353 (13): 1332-1341
96. Bernard GR, Vincent JL, Laterre PF, et al., on behalf of the recombinant human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 Mar 8; 344 (10): 699-709
97. Sward K, Valsson F, Sellgren J, et al. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005 Jan; 31 (1): 79-85
98. Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furo-semide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000 Feb; 69 (2): 501-506
99. Hirschberg R, Kopple J, Lipsett P, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999 Jun; 55 (6): 2423-2432
100. Vesey DA, Cheung C, Pat B, et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004 Feb; 19 (2): 348-355
101. Wu X, Guo R, Chen P, et al. TNF induces caspase-dependent inflammation in renal endothelial cells through a rho-and myosin light chain kinase-dependent mechanism. Am J Physiol Renal Physiol 2009 Aug; 297 (2): F316-26
102. Chatterjee PK, Todorovic Z, Sivarajah A, et al. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney. Eur J Pharmacol 2004 Oct 25; 503 (1-3): 173-183
103. Yamamoto K, Tomita N, Yoshimura S, et al. Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: role ofBcl-2, Bcl-xL and Baxintubular injury. Int J Mol Med 2004 Oct; 14 (4): 633-640
104. Baskin-Beya ES, Washburn K, Fengc S, et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 2007; 7: 218-225
105. Fischer U, Janssen K, Schulze-Osthoff K. Does caspase inhibition promote clonogenic tumor growth? Cell Cycle 2007 Dec 15; 6 (24): 3048-3053
106. Kelly KJ, Sutton TA, Weathered N, et al. Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am J Physiol Renal Physiol 2004 Oct; 287 (4): F760-6
107. Sutton TA, Kelly KJ, Mang HE, et al. Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury. Am J Physiol Renal Physiol 2005 Jan; 288 (1): F91-7
108. Mao H, Li Z, Zhou Y, et al. HSP72 attenuates renal tubu-lar cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2008 Jul; 295 (1): F202-14
109. Liu L, Yang C, Herzog C, et al. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol 2010; 79 (2): 137-146
110. Kelly KJ, Plotkin Z, Dagher PC. Guanosine supple-mentation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 2001 Nov; 108 (9): 1291-1298
111. Kelly KJ, Plotkin Z, Vulgamott SL, et al. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 2003 Jan; 14 (1): 128-138
112. Cauwels A, Janssen B, Waeytens A, et al. Caspase inhibi-tion causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 2003 Apr; 4 (4): 387-393 (Pubitemid 36432323)
113. Sethi S, Sahani M, Oei LS. ANCA-positive crescentic glo-merulonephritis associated with minocycline therapy. Am J Kidney Dis 2003 Aug; 42 (2): E27-31
114. Yasuda H, Yuen PS, Hu X, et al. Simvastatin im-proves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006 May; 69 (9): 1535-1542
115. Daynes RA, Jones DC. Emerging roles of PPARs in in-flammation and immunity. Nat Rev Immunol 2002 Oct; 2 (10): 748-759
116. Li S, Gokden N, Okusa MD, et al. Antiinflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol 2005 Aug; 289 (2): F469-80
117. Kabay B, Kocaefe YC, Baykal A, et al. Liposome-mediated intraperitoneal interleukin 10 gene transfer increases survival in cecal litigation and puncture model of sepsis. Shock 2006 Jul; 26 (1): 37-40
118. Wu L, Mayeux PR. Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on micro-circulation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice. J Pharmacol Exp Ther 2007 Mar; 320 (3): 1061-1067
119. Cobb JP. Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red. Crit Care Med 1999 May; 27 (5): 855-856
120. Miyaji T, Hu X, Yuen PS, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 2003; 64 (5): 1620-1631
121. Leelahavanichkul A, Yasuda H, Doi K, et al. Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. Am J Physiol Renal Physiol 2008 Dec; 295 (6): F1825-35
122. Linden J. Molecular approach to adenosine receptors: re-ceptor mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001; 41: 775-787
123. Day YJ, Huang L, McDuffie MJ, et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 2003 Sep; 112 (6): 883-891
124. Lee HT, Ota-Setlik A, Xu H, et al. A3 adenosine receptor knockout mice are protected against ischemia-and myo-globinuria-induced renal failure. Am J Physiol Renal Physiol 2003 Feb; 284 (2): F267-73
125. Lee HT, Gallos G, Nasr SH, et al. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2004 Jan; 15 (1): 102-111
126. Dear JW, Leelahavanichkul A, Aponte A, et al. Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure. Crit Care Med 2007 Oct; 35 (10): 2319-2328
127. Doi K, Hu X, Yuen PS, et al. AP214, an analogue of alpha-melanocyte- stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int 2008 Jun; 73 (11): 1266-1274
128. Gulmen S, Kiris I, Narin C, et al. Tezosentan reduces the renal injury induced by abdominal aortic ischemia-reperfusion in rats. J Surg Res 2009 Nov; 157 (1): e7-13. Epub 2008 Oct 24
129. Miloradovic Z, Jerkic M, Jovovic D, et al. Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade. Nephrol Dial Transplant 2007 Sep; 22 (9): 2476-2484
130. Patel NN, Jones C, Lin H, et al. Functional, morphological and cytochemical changes in a large animal recovery model of post-cardiopulmonary bypass acute kidney injury [abstract]. Intensive Care Med 2009 Sep; 35 Suppl. 1: A 0433, 114
131. Lee KW, Jeong JY, Lim BJ, et al. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 2009 Mar; 257 (3): 137-143
132. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004 Dec; 15 (12): 3073-3082
133. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621
134. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005 Apr 2-8; 365 (9466): 1231-1238
135. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003 Oct; 14 (10): 2534-2543
136. Haase M, Bellomo R, Schlattmann P, et al., on behalf of the NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009 Dec; 54 (6): 1012-1024
137. Sato W, Takei Y, Yuzawa Y, et al. Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Kidney Int 2005 Apr; 67 (4): 1330-1339
138. West AP, Koblansky AA, Ghosh S. Recognition and sig-naling by Toll-like receptors. Annu Rev Cell Dev Biol 2006; 22: 409-437
139. Cunningham PN, Wang Y, Guo R, et al. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 2004 Feb 15; 172 (4): 2629-2635
140. Pulskens WP, Teske GJ, Butter LM, et al. Toll-like re-ceptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One 2008; 3 (10): e3596
141. Sharfuddin AA, Sandoval RM, Berg DT, et al. Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol 2009 Mar; 20 (3): 524-534
142. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008 May; 73 (9): 1008-1016
143. Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008 Feb; 73 (4): 465-472 (Pubitemid 351186293)
144. Haase-Fielitz A, Haase M, Bellomo R, et al. Genetic polymorphisms in sepsis-and cardiopulmonary bypass-associated acute kidney injury. Contrib Nephrol 2007; 156: 75-91
145. Jaber BL, Pereira BJ, Bonventre JV, et al. Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. Kidney Int 2005 Jan; 67 (1): 14-33
146. Perianayagam MC, Liangos O, Kolyada AY, et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007 Jan; 18 (1): 255-263
147. Chew ST, Newman MF, White WD, et al. Preliminary re-port on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 2000 Aug; 93 (2): 325-331
148. Treszl A, Toth-Heyn P, Kocsis I, et al. Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 2002 Sep; 17 (9): 713-717
149. Gaudino M, Di Castelnuovo A, Zamparelli R, et al. Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery. J Thorac Cardiovasc Surg 2003 Oct; 126 (4): 1107-1112
150. Wattanathum A, Manocha S, Groshaus H, et al. Interleu-kin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 2005 Sep; 128 (3): 1690-1698
151. Stafford-Smith M, Podgoreanu M, Swaminathan M, et al., on behalf of the Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005 Mar; 45 (3): 519-530